Study Finds Evidence Of Higher Consciousness From Psychedelics
Scientists have found the first evidence of a higher state of consciousness by measuring the complexity of brain activity of people under the influence of psychedelics. The study measured magnetic fields generated by brain activity and used the data to create an index of varying levels of consciousness.
The study, conducted by a team at the University of Sussex in England, looked at the diversity of brain signals, a measure of the complexity of brain activity, in people under the influence of psilocybin, LSD, and ketamine, compared to the brain activity of people in lower levels of consciousness, such as sleep, anesthesia, and ‘vegetative’ states.
Participants under the influence of these drugs showed higher than baseline diversity, or higher levels than someone who is simply awake. This is the first time a measure of an elevated consciousness has been recorded in a study of its kind.
The researchers were quick to point out that their measure of higher consciousness doesn’t necessarily imply that the psychedelic state is better or higher functioning than our normal waking state. Instead the index they’ve used shows that the psychedelic state increases small magnetic fields produced by the brain and higher neural-signal diversity in all three types of drugs.
According to the study, “During the psychedelic state, the electrical activity of the brain is less predictable and less ‘integrated’ than during normal conscious wakefulness.”
One researcher involved in the study, Dr. Muthukumaraswamy, said he was surprised the results were consistent with each drug, despite their differing pharmacology. He and his colleagues believe that their research could lead to carefully-controlled use of the drug for therapeutic treatment in patients suffering from severe depression.
The group found correlation between participants’ reports of changes in intensity of the psychedelic experience and changes in brain signal diversity. They believe this shows there is a difference in aspects of brain activity in our everyday conscious experience.
This study comes after recent trials have shown psilocybin can flip a “reset” mechanism in the brains of people suffering from depression. Similar studies found benefits in the therapeutic use of ketamine and LSD for people suffering from a range of physical and psychiatric issues, including drug addiction and PTSD.
Similar studies have been conducted to test electroencephalography, or EEG, on participants in deep states of meditation, finding increased levels of alpha and theta wave activity. It’s unclear whether this recent study plans on testing participants levels of brain-signal diversity in non-intoxicated, altered states of consciousness.
About the Author
Psychedelic-Assissted Therapy for Veterans and Personality Improvement
Psychedelic-assisted therapy at the VA
Psychedelic-assisted therapy has recently gained mainstream acceptance among civilians, but what about for members of the military and veterans?
This therapy may soon be an option for some veterans. As “Lucid” reports, “psychedelic-assisted therapy is on the rise at some veterans administration hospitals.”
Phase 3 clinical trials of MDMA therapy to treat post-traumatic stress disorder have been so successful, with 68 percent of participants in remission, the FDA granted MDMA a special ‘Breakthrough Therapy’ designation. But this therapy is not yet available all over the country, prompting more researchers to call on the VA to create protocols for MDMA, psilocybin, and ketamine therapies. These psychedelics are still classified as Schedule 1 narcotics, and it will take political will and bipartisan support to win FDA approval.
If that happens, researchers at the forefront of these therapies hope to see VA hospitals nationwide using psychedelics to help veterans by the year 2024.
